Factors Associated with Survey Non-Response in a Cross-Sectional Survey of Persons with an Axial Spondyloarthritis or Osteoarthritis Claims Diagnosis.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
09 12 2020
Historique:
received: 10 11 2020
revised: 06 12 2020
accepted: 07 12 2020
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 12 2 2021
Statut: epublish

Résumé

Non-response in surveys can lead to bias, which is often difficult to investigate. The aim of this analysis was to compare factors available from claims data associated with survey non-response and to compare them among two samples. A stratified sample of 4471 persons with a diagnosis of axial spondyloarthritis (axSpA) and a sample of 8995 persons with an osteoarthritis (OA) diagnosis from a German statutory health insurance were randomly selected and sent a postal survey. The association of age, sex, medical prescriptions, specialist physician contact, influenza vaccination, hospitalization, and Elixhauser comorbidity index with the survey response was assessed. Multiple logistic regression models were used with response as the outcome. A total of 47% of the axSpA sample and 40% of the OA sample responded to the survey. In both samples, the response was highest in the 70-79-year-olds. Women in all age groups responded more often, except for the 70-79-year-olds. Rheumatologist/orthopedist contact, physical therapy prescription, and influenza vaccination were more frequent among responders. In the logistic regression models, rheumatologist/orthopedist treatment, influenza vaccination, and physical therapy were associated with a higher odds ratio for response in both samples. The prescription of biologic drugs was associated with higher response in axSpA. A high Elixhauser comorbidity index and opioid use were not relevantly associated with response. Being reimbursed for long-term care was associated with lower response-this was only significant in the OA sample. The number of quarters with a diagnosis in the survey year was associated with higher response. Similar factors were associated with non-response in the two samples. The results can help other investigators to plan sample sizes of their surveys in similar settings.

Identifiants

pubmed: 33316981
pii: ijerph17249186
doi: 10.3390/ijerph17249186
pmc: PMC7764396
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Med Res Methodol. 2020 Oct 8;20(1):252
pubmed: 33032531
Acta Orthop. 2013 Feb;84(1):12-7
pubmed: 23343374
Z Rheumatol. 2019 Dec;78(Suppl 2):73-79
pubmed: 31342161
BMC Med Res Methodol. 2015 Oct 05;15:78
pubmed: 26438235
Ann Rheum Dis. 2015 Jan;74(1):156-63
pubmed: 24255544
Ann Rheum Dis. 2018 Jul;77(7):1017-1024
pubmed: 29525776
BMC Musculoskelet Disord. 2006 Mar 16;7:30
pubmed: 16542454
Int J Epidemiol. 2020 Apr 1;49(2):629-637
pubmed: 31990354
Eur J Health Econ. 2017 Jun;18(5):533-536
pubmed: 27878393
Respir Med. 2020 Nov;173:106017
pubmed: 33190739
BMC Med Res Methodol. 2019 May 3;19(1):91
pubmed: 31053088
Rheumatol Int. 2018 Nov;38(11):2121-2131
pubmed: 30094685
PLoS One. 2019 Dec 18;14(12):e0226255
pubmed: 31851711
Cochrane Database Syst Rev. 2009 Jul 08;(3):MR000008
pubmed: 19588449
Ann Rheum Dis. 2014 Jul;73(7):1323-30
pubmed: 24553908
Rheumatol Int. 2020 Feb;40(2):257-261
pubmed: 31784790
Arthritis Care Res (Hoboken). 2020 Feb;72(2):193-200
pubmed: 31479193
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720958532
pubmed: 32930035
BMC Public Health. 2012 Oct 29;12:918
pubmed: 23107281
Arthritis Rheumatol. 2020 Feb;72(2):220-233
pubmed: 31908163
J Clin Epidemiol. 2012 Nov;65(11):1181-9
pubmed: 22906867
Respir Med. 2020 Sep;171:106087
pubmed: 32917358
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):620-30
pubmed: 23703478
Z Rheumatol. 2020 Feb;79(1):85-94
pubmed: 31359143
Obs Stud. 2016;2:24-38
pubmed: 28042621
BMC Musculoskelet Disord. 2017 Jun 28;18(1):278
pubmed: 28659134
Health Policy. 2016 Feb;120(2):213-26
pubmed: 26826756
BMC Fam Pract. 2018 May 30;19(1):77
pubmed: 29848292
Gesundheitswesen. 2004 Aug-Sep;66(8-9):482-91
pubmed: 15372348
Nat Rev Dis Primers. 2015 Jul 09;1:15013
pubmed: 27188328
J Med Econ. 2013;16(5):667-77
pubmed: 23425294
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328

Auteurs

Johanna Callhoff (J)

Epidemiology, German Rheumatism Research Centre, 10117 Berlin, Germany.

Hannes Jacobs (H)

Department of Health Services Research, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany.

Katinka Albrecht (K)

Epidemiology, German Rheumatism Research Centre, 10117 Berlin, Germany.

Joachim Saam (J)

Department Medicine and Health Services Research, BARMER Institute for Health System Research, BARMER, 73525 Schwäbisch-Gmünd, Germany.

Angela Zink (A)

Epidemiology, German Rheumatism Research Centre, 10117 Berlin, Germany.
Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, 10117 Berlin, Germany.

Falk Hoffmann (F)

Department of Health Services Research, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH